Advances in clinical application research of mycobacterium vaccae on treatment of tuberculosis

doi:10.19871/j.cnki.xfcrbzz.2020.04.013

Abstract

Abstract: As an adjunct to chemotherapy,Mycobacterium vaccae is helpful for patients with initial treatment of tuberculosis,recurrent treated tuberculosis,multi-drμg resistant tuberculosis,tuberculous pleurisy and TB preventive treatment in terms of improving cell-medicated immunity.This article aims to briefly describe the clinical application and research progress of Mycobacterium vaccae in the adjuvant treatment of tuberculosis in recent years.

Key words: Mycobacterium vaccae, Clinical application, Immunotherapy, Tuberculosis

Liu Chunling, Yan Xiaofeng. Advances in clinical application research of mycobacterium vaccae on treatment of tuberculosis[J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(4): 274-276.

References

[1] Skinner MA,Yuan S,Prestidge R,et al.Immunization with heatkilled Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis[J].Infect Immun,1997,65(10):4525-4530.
[2] Stanford JL,BahR GM,Rook GAM,et al.Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis[J].Tubercle,1990,71:87.
[3] Huang CY,Hsieh WY.Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis:A systematic review and meta-analysis[J].Hum Vaccin Immunother,2017,13(9):1960-1971.
[4] Bourinbaiar AS,Batbold U,Efremenko Y,et al.Phase III,placebo-controlled,randomized,double-blind trial of tableted,therapeutic TB vaccine (V7) containing heat-killed M.vaccae administered daily for one month[J].J Clin Tuberc Other Mycobact Dis,2020,18:100141.
[5] 刘敏.母牛分支杆菌菌苗在初治肺结核治疗中的作用[J].国际感染病学(电子版),2019,8(2):18-19.
[7] 陈珣珣,周琳,陈志宇,等.母牛分枝杆菌菌苗应用于涂阴肺结核超短程治疗方案的临床观察[J].广东医科大学学报,2019,37(3):261-264.
[7] 范妙仪,陈雪融,王可.等.母牛分枝杆菌菌苗辅助治疗复治肺结核的Meta分析[J].中国循证医学杂志,2007,7(6):449-455.
[8] 林松.微卡辅助治疗复治涂阳肺结核的疗效分析[J].中外医疗,2017(5):83-85.
[9] 李生荣.微卡配合抗结核药物治疗复治难治菌阳肺结核43例临床观察[J].宁夏医学杂志,2019,41(11):1010-1012.
[10] Weng H,Huang JY,Meng XY,et al.Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrμg -resistant tuberculosis:A systematic review and meta-analysis[J].Biomed Rep,2016(4):595-600.
[11] 崔丹,冯秀莉,李志惠.等.利奈唑胺与微卡联用对耐多药肺结核的免疫功能影响及临床疗效分析[J].解放军预防医学杂志,2020,38(6):61-63.
[12] 王继业.微卡联合化疗药物治疗耐多药肺结核的疗效观察[J].中国医药指南,2017,15(5):159-160.
[13] 张凡.微卡联合化疗药物治疗耐多药肺结核疗效观察[J].黑龙江医药,2016,29(6):1141-1142.
[14] 蒋洪.注射用母牛分枝杆菌(微卡)联合莫西沙星对耐多药肺结核患者的临床研究[J].检验医学与临床,2017,14(14):2080-2085.
[15] 费贤树,曾谊,林云霞,等.母牛分枝杆菌辅助治疗结核性胸膜炎的Meta分析[J].中华临床医师杂志,2013,7(12):5432-5438.
[16] 王晓平.尿激酶联合微卡胸腔内注入治疗结核性胸膜炎疗效观察[J].现代中西医结合杂志,2013,22(3):284-285.
[17] 崔泰震,韩伟,黄健,等.母牛分枝杆菌菌苗在结核性胸膜炎治疗中的作用[J].临床肺科杂志,2011,16(7):1052-1053.
[18] 高德杰,霍丽丽,劳海黎,等.母牛分枝杆菌在治疗潜伏性结核感染中的细胞免疫学作用机制[J].中华医院感染学杂志,2016,26(7):1480-1482.
[19] Von Reyn CF,Mtei L,Arbeit RD,et al.Prevention of tuberculosis in Bacille Calmette-Guérin-primed,HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine[J].AIDS,2010,24:675.
[20] World Health Organization.Global tuberculosis report2018[R].Geneva:WHO,2018.https://www.who.int/tb/publications/global_report/en/.
[21] World Health Organization.Global tuberculosis report2019[R].Geneva:WHO,2019.https://www.who.int/tb/publications/global_report/en/.

[1]	Song Shulin, Lu Yibo, Peng Renping, Zhang Shiqian, Mo Yimei, Zhou Jingru. Curative effect observation on anti-tuberculosis therapy for AIDS patients complicated with mediastinal lymph node tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(4): 253-257.
[2]	Wang Zhengyuan, Liu Heng, Lu Hong. Intestinal tuberculosis: X-ray barium meal radiography, CT imaging findings [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(4): 265-267.
[3]	Ren Tantan, Lu Puxuan, Deng Guofang. 2020WHO tuberculosis report: key data for China, the whole world [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(4): 280-284.
[4]	Tan Weiguo, Guan Hongyun, Wu Qingfang, Lu Puxuan, Hong Chuangyue, Lai Peixuan, Li Mingzhen, Chen Rong, Yu Weiye. The implement effects and innovative strategies for tuberculosis controlling among migrants [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(3): 145-149.
[5]	Zhuo Zhipeng, Wu Qingfang, Lai Peixuan, Lu Chunrong, Yu Weiye, Tan Weiguo. Investigation and analysis on tuberculosis report of medical institutions in Shenzhen in 2018 [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(3): 191-194.
[6]	Qi Wanling, Wu Yingying, Zhu Xuechao, Wan Tianyi, Tang Xin, He Yulin. The clinical application value of high filed MRI in the examination and diagnosis of pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(3): 212-214.
[7]	Fang Weijun, Song Min, Han Yuanyuan, Liu Zhihui. Analysis of MRI imaging features with intracranial tuberculosis and changes of imaging during antituberculosis treatment [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(2): 107-112.
[8]	Xu Jinwei, Zhang Xin, Chen Zhen. Comparative analysis of CT findings between non-tuberculous mycobacterial pulmonary disease and secondary pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(2): 113-117.
[9]	Wu Yumei, Luo Ziyi, Peng Jinfu. Evaluation of Mycobacterium tuberculosis 16Sr RNA+DNA and 23S DNA detection in diagnosis and treatment of pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(2): 118-121.
[10]	Zhang Xiaoqi, Liu Jingyuan, Li Minlu, Qu Zhijun, Tan Weiguo. Analysis of the cost of isolation treatment and the infection of sputum bacteria in 56 patients with smear positive pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(1): 28-31.
[11]	Luo Yiting, Weng Rongxing, Zhou Fang, Yu Weiye, Lu Puxuan. 2019 WHO Tuberculosis Report: key data analysis for global and China [J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(1): 47-50.
[12]	HE Zhan-ping, CHEN Jing, XU Hai-xia, LU Hong. Imaging diagnosis and differential diagnosis of the hepatic tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 212-216.
[13]	JI Le-cai, YU Wei-ye, TAN Wei-guo, LV De-liang, LV Jian-wen. Clinical observation and adverse reactions analysis of linezolid in the treatment of severe multi-drug resistant pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 217-219.
[14]	LIAO Feng-xiang, LUO Zhe-huang, JIN Ai-fang, QI Wan-ling. Embolization treatment of severe hemoptysis in patients with pulmonary tuberculosis [J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 227-230.
[15]	FANG Wei-jun, SONG Min, HAN Yuan-yuan, LI Hui-ru, ZHANG Hui, REN Hui-li, LIU Wen. Characteristic CT images of pulmonary tuberculosis in children under three years of age [J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 252-256.